Meanwhile, most B-ALL patients (77%) tendto express BCR::ABL/p190 while a smaller proportion of patients (20%) expressBCR::ABL/p210, and the remainder (3%) co-express BCR::ABL/p190 andBCR::ABL/p210 [5]. This evidence concerns the gene CNTNAP1 and acute lymphoblastic leukemia.